GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AdaptHealth Corp (NAS:AHCO) » Definitions » 3-Year ROIIC %

AHCO (AdaptHealth) 3-Year ROIIC % : 6.17% (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is AdaptHealth 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. AdaptHealth's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 6.17%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for AdaptHealth's 3-Year ROIIC % or its related term are showing as below:

AHCO's 3-Year ROIIC % is ranked better than
58.9% of 820 companies
in the Medical Devices & Instruments industry
Industry Median: -1.765 vs AHCO: 6.17

AdaptHealth 3-Year ROIIC % Historical Data

The historical data trend for AdaptHealth's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdaptHealth 3-Year ROIIC % Chart

AdaptHealth Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial - - 4.18 2.53 6.17

AdaptHealth Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.17 - - -

Competitive Comparison of AdaptHealth's 3-Year ROIIC %

For the Medical Devices subindustry, AdaptHealth's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AdaptHealth's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AdaptHealth's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where AdaptHealth's 3-Year ROIIC % falls into.



AdaptHealth 3-Year ROIIC % Calculation

AdaptHealth's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 216.6534678 (Dec. 2023) - 67.207932 (Dec. 2020) )/( 4039.524 (Dec. 2023) - 1618.062 (Dec. 2020) )
=149.4455358/2421.462
=6.17%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


AdaptHealth  (NAS:AHCO) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


AdaptHealth 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of AdaptHealth's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


AdaptHealth Business Description

Traded in Other Exchanges
N/A
Address
220 West Germantown Pike, Suite 250, Plymouth Meeting, PA, USA, 19462
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Executives
Dale B Wolf director
Shaw Rietkerk officer: Chief Revenue Officer C/O ADAPTHEALTH LLC, 220 WEST GERMANTOWN PIKE, SUITE 250, PLYMOUTH MEETING PA 19462
Williams David Solomon Iii director 6272 CONDON AVE, LOS ANGELES CA 90056
James E Flynn director, 10 percent owner, other: Director by Deputization 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Albert A. Prast officer: Chief Technology Officer 3325 BARTLETT BLVD., ORLANDO FL 32811
Skyknight Aero Holdings, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Jason A Clemens officer: Chief Financial Officer 220 WEST GERMANTOWN PIKE, SUITE 250, C/O ADAPTHEALTH LLC, PLYMOUTH MEETING PA 19462
Christine E. Archbold officer: Chief Accounting Officer FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Everest Hill Group Inc. 10 percent owner TROPIC ISLE BUILDING, P O BOX 3331, ROAD TOWN TORTOLA D8 VG 1110
Daniel Bunting officer: COO - Branch Operations 12200 N.W. AMBASSADOR DRIVE, SUITE 326, KANSAS CITY MO 64163
Christopher J Joyce officer: General Counsel C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022
Skyknight Aero Holdings Ii, Llc director C/O SKYKNIGHT CAPITAL, L.P., ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital, L.p. director C/O SKYKNIGHT CAPITAL, ONE LETTERMAN DR., BLDG. C, SUITE 3-950, SAN FRANCISCO CA 94129
Skyknight Capital Fund Ii, L.p. director ONE LETTERMAN DRIVE, BUILDING C, SUITE 3-950, SAN FRANCISCO CA 94129
Stephen P Griggs director, officer: Co-Chief Executive Officer 1360 PLACE VENDOME, WINTER PARK FL 32789